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Introduction
The presence of methylated CpGs in the DNA sequence of a
promoter is generally incompatible with gene expression in
animal somatic cells (Bird, 2002). Over 70% of CpGs in
vertebrate DNA contain the 5-methyl cytosine modification,
presenting a potential for global gene silencing. Distinct
patterns of DNA methylation exist at specific loci, which can
vary between different tissues and developmental stages. In
Xenopus laevis embryos, global DNA methylation levels are
high in early stages, but drop by about 40% in late blastula and
subsequently recover during later gastrula stages (Stancheva et
al., 2002; Stancheva and Meehan, 2000). This correlates with
the period of transcriptional quiescence observed during the
first 12 cleavage cycles of Xenopus development. Transcription
activation begins in a coordinated manner at the midblastula
transition (MBT), when DNA methylation levels decrease,
accompanied by changes in chromatin composition and
increased activity of the basal transcription machinery
(Almouzni et al., 1994; Almouzni and Wolffe, 1995; Newport
and Kirschner, 1982a; Newport and Kirschner, 1982b; Veenstra
et al., 1999).
The general model for indirect repression by DNA
methylation predicts that methyl-CpG binding proteins
mediate silencing in pre-MBT embryos by recruiting
enzymatic complexes that modify local chromatin structure
(Jones et al., 1998; Nan et al., 1998; Wade et al., 1999). This
results in a closed heterochromatic structure that is refractory
to transcription (Jaenisch and Bird, 2003). Conversely, loss of
DNA methylation can lead to a relaxation in chromatin-based
silencing mechanisms in somatic cells such that the threshold
for gene activation and consequent developmental potential
is altered (Jaenisch and Bird, 2003; Meehan, 2003). In
Xenopus, as in mice, inactivation of the maintenance DNA
methyltransferase xDnmt1 results in hypomethylation of
genomic DNA, ectopic expression of normally silent genes and
embryonic lethality (Jackson-Grusby et al., 2001; Stancheva
and Meehan, 2000). xDnmt1 deficient embryos exhibit
premature gene expression at least two cell cycles earlier than
normal (prior to the MBT), implying that the correct timing of
zygotic activation is regulated in part by the repressive effect
of DNA methylation during early blastula stages (Stancheva
and Meehan, 2000).
In mammals, three repressor proteins, MeCP2, MBD1 and
MBD2, bind methylated CpGs via a conserved motif called the
methyl-CpG binding domain (Cross et al., 1997; Hendrich and
Bird, 1998). The MBD motif is ~70 amino acids long and is
found in a diverse number of nuclear proteins, only a subset of
which can bind methylated DNA (Hendrich and Tweedie,
DNA methylation in animals is thought to repress
transcription via methyl-CpG specific binding proteins,
which recruit enzymatic machinery promoting the
formation of inactive chromatin at targeted loci. Loss of
DNA methylation can result in the activation of normally
silent genes during mouse and amphibian development.
Paradoxically, global changes in gene expression have not
been observed in mice that are null for the methyl-CpG
specific repressors MeCP2, MBD1 or MBD2. Here, we
demonstrate that xKaiso, a novel methyl-CpG specific
repressor protein, is required to maintain transcription
silencing during early Xenopus laevis development. In the
absence of xKaiso function, premature zygotic gene
expression occurs before the mid-blastula transition
(MBT). Subsequent phenotypes (developmental arrest
and apoptosis) strongly resemble those observed for
hypomethylated embryos. Injection of wild-type human
kaiso mRNA can rescue the phenotype and associated gene
expression changes of xKaiso-depleted embryos. Our
results, including gene expression profiling, are consistent
with an essential role for xKaiso as a global repressor of
methylated genes during early vertebrate development.
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2003). In vitro and transient transfection experiments provide
good evidence that MeCP2, MBD1 and MBD2 act as
transcriptional repressors of methylated reporter templates
(Nan et al., 1997; Ng et al., 1999; Ng et al., 2000). In addition,
chromatin immunoprecipitation (ChIP) experiments localise
MeCP2, MBD2 and MBD1 to methylated and silenced genes.
The chromatin of these genes is also hypoacetylated and
contains H3 that is methylated on lysine 9 (H3K9Me), both
hallmarks of inactive chromatin (Ballestar et al., 2003; Gregory
et al., 2001). A number of histone deacetylases (HDAC) and
histone methyltransferases (HMT) are associated with MeCP2,
MBD1, MBD3 and DNA methyltransferases. This reinforces
the mechanistic link between DNA methylation and specific
histone modifications in promoting gene silencing (Jaenisch
and Bird, 2003).
Mbd2–/–-derived embryonic cells have a reduced ability to
repress methylated reporter genes in transient transfection
assays, and the activation threshold of specific genes is altered
upon differentiation (Hendrich et al., 2001; Hutchins et al.,
2002). However, the expectation that MeCP/MBDs might act
as global repressors of transcription from methylated templates
in vivo was not supported: the absence of MeCP2, MBD1 or
MBD2 function does not disrupt specific programs of
developmental gene expression in mice (including X-
chromosome inactivation), nor does it phenocopy the effects of
Dnmt1 inactivation (Chen et al., 2001; Guy et al., 2001;
Hendrich et al., 2001; Tudor et al., 2002; Zhao et al., 2003).
Only MBD3 is required for early murine development, but as
this MBD does not actually bind methylated DNA, MBD3–/–
embryo lethality is probably the result of its role as a core
component of the NuRD/MeCP1 transcription repressor
complex (Hendrich et al., 2001).
A very different methylated DNA-dependent binding
domain was identified in the transcriptional repressor kaiso
(ZBTB33 – Human Gene Nomenclature Database), which
binds methyl CpGs through a zinc-finger (ZF) motif
(Prokhortchouk et al., 2001). Kaiso recognizes DNA sequences
that contain at least two methyl-CpGs, and represses
transcription from reporter templates in a methyl-CpG-
dependent manner (Prokhortchouk et al., 2001; Yoon et al.,
2003). It was originally discovered in a two-hybrid screen
using the cell adhesion co-factor p120ctn as bait (Daniel and
Reynolds, 1999). Like the armadillo-related protein β-catenin,
to which it is structurally homologous, p120ctn interacts with
the cytoplasmic domain of the transmembrane cell adhesion
molecule E-cadherin. Kaiso could possibly mediate p120ctn/E-
cadherin signalling to the nucleus to regulate the expression of
methylated target genes. In HeLa cells, kaiso mediates
silencing of the MTA2 gene by interacting with the N-CoR co-
repressor complex via its POZ domain (Yoon et al., 2003). A
Xenopus homologue, xKaiso, has recently been described (Kim
et al., 2002). We noted that its expression pattern matched that
of xDnmt1 (A.R. and R.M., unpublished), which hinted that it
could have a potential role in regulating transcription silencing
in pre-MBT embryos (Stancheva and Meehan, 2000).
We wished to determine the binding specificity of xKaiso
and its ability to act as a methylation-dependent repressor, and
to investigate its role in transcriptional silencing during early
amphibian development. We show that xKaiso has a similar,
if not more pronounced preference for methylated DNA
compared with its mammalian counterpart. Depletion of
xKaiso function in Xenopus embryos results in premature
activation of pre-MBT zygotic transcription. The depletion
phenotype can be rescued by overexpression of wild-type
human kaiso, but not by a mutant lacking a functional methyl-
CpG binding domain. Our analysis suggests that xKaiso is
essential for methylation-dependent transcriptional silencing in
early amphibian embryos.
Materials and methods
Plasmids and recombinant proteins
GST-xKaiso ZF encoded the xKaiso zinc fingers (amino acids 470-
609; AY044336) cloned in frame into pGEX-4T1. GST-hKaiso and
GST-C552RhKaiso fusions were cloned into pGEX-2T. Point
mutation C552R was generated by QuikChange® Site-Directed
Mutagenesis (Stratagene) using GGGGAGCGAAGGTATCAG-
CGTTTGGCCTGTGGC and reverse complement primer. Proteins
were expressed in BL-21 cells and purified on GST Sepharose.
EMSA experiments
Binding reactions were as described using 5% PAGE in 0.3TBE to
resolve DNA-protein complexes with Non-Sm and Me-Sm probes
(Prokhortchouk et al., 2001) and the human matrilysin (Hmat) oligo
(Daniel et al., 2002).
Methyl CpG-dependent repression test
The ability of xKaiso to repress transcription from a methylated
reporter gene using Mbd2–/– cells was performed as described
previously (Hendrich et al., 2001; Prokhortchouk et al., 2001).
Protein extracts and immunoblots
Total protein extracts for western blotting were prepared from staged
wild-type eggs, and wild-type and KMO-injected blastulae and
gastrulae as described (Stancheva et al., 2001). Extracts were run in
10% SDS-polyacrylamide gels and electro-transferred to PVDF
membrane. xKaiso was detected by a monoclonal antibody against the
conserved N-terminal domain of mouse kaiso (Zymed, clone 6F).
Anti-mouse HRP-conjugated IgGs were used as secondary antibodies.
Kaiso – p120 catenin interaction test
p120 mouse cDNA (forms 1A and 3A) was cloned into pFASTBAC1
vector (Invitrogen) from pMS2-p1201A and pMS2-p1203A (provided
by Dr Al Reynolds). The proteins (1A and 3A – co-transfected) were
expressed in Sf9 insect cells using the Bac-to-Bac Baculovirus
Expression System (Invitrogen). Cell extracts were added to GST-
Kaiso Sepharose, incubated for 1 hour at room temperature, washed
three times with PBS. Bound proteins were eluted with glutathione
and resolved by SDS-PAGE, blotted and visualised with antibodies
specific either to p120 catenin (mAb clone 15D2) or to kaiso (ZF6).
Embryos and microinjections
Xenopus embryos were obtained from in vitro fertilized wild-type and
albino eggs or by natural mating of sexually mature frogs. They were
grown, staged and microinjected according to standard procedures
(Stancheva and Meehan, 2000). At the two-cell stage, the embryos
were injected into the animal half of the embryos with 0.5-10 ng/cell
of xKaiso morpholino oligo (KMO), GATCAGCTTTTTTGTCT-
CCATGTCT; xDnmt1 morpholino oligo (DMO), GGACAGGCGT-
GAAACAGACTCGGC; or control morpholino, CGCTCAGCT-
CCTCCATGTCTGCCGC (Gene-Tools); and/or 200-750 pg of sense
capped RNA synthesized in vitro (T3/T7 Cap-Scribe kit, Boehringer).
Whole-embryo run-on experiments with [α-35S]UTP incorporation
were performed using 5 ng KMO-injected and wild-type embryos, as
described (Stancheva and Meehan, 2000). The whole-mount TUNEL
staining of embryos was as described previously (Hensey and Gautier,
1998).
Development 131 (24) Research article
6187DNA methylation and development
RT-PCR analysis
RNA was isolated as described previously (Stancheva and Meehan,
2000). cDNA was synthesised from five embryos using Superscript II
reverse transcriptase (RT) (Invitrogen). RT-PCR was performed over
a range of cDNA dilutions and PCR cycles to ensure exponential
amplification. xODC was used as a loading control, and cDNA was
synthesised in the absence of RT to control for genomic DNA
contamination. Primer sequences used were: xBEF-U, 5′-CCGAAA-
CAGCTTCCAGACAA-3′; xBEF-L, 5′-TGAAAGGAAAGCAGA-
CGCTC-3′; xDRAK1-U, 5′-ACCGAGAGGAGGAAGTCACT-3′;
xDRAK-L, 5′- GGCTTAAAGGAAACAAGTCC-3′; xOct-25-U, 5′-
TAATGGAGAGATGCTTGATG-3′; xOct-25-L, 5′-TTCTCTATGT-
TCGTCCTCC-3′; xODC-U, 5′-GGAGCTGCAAGTTTGGAGA-3′;
xODC-L, 5′-TCAGTTGCCAGTGTGGTC-3′.
Magex array hybridisation and analysis
cDNA filters were obtained from Viagenx (Canada). Arrays were
probed as described previously with minor modifications (Helbing et
al., 2003). In brief, Xenopus total RNA was isolated and cDNA was
synthesised using the SuperSMART kit (Clontech, USA) (Barnett et
al., 1998). cDNA was amplified in the exponential phase by PCR
using 21-23 cycles at an annealing temperature of 63°C. cDNA probes
were labelled with [α-32P]dCTP by random priming using the
HexaLabel kit (Fermentas, UK). Arrays were hybridised in Church &
Gilbert hybridisation solution (0.5 M Na2HPO4, 7% SDS, 1 mM
EDTA, pH 7.2) at 65°C and washed to high stringency in 40 mM
Na2HPO4, 1% SDS at 65°C. Images were acquired using AIDA
software and the FLA2000 phosphorimager. Scanalyze (Eisen et al.,
1998) was used to acquire gene spot intensities and non-signal
backgrounds. Data across hybridisation experiments were normalised
to the 18S rRNA spots intensity.
CpG island analysis
DNA sequences were analysed using the CpG island analysis tool
at the Potential Promoter Regulatory Element Database
(http://idealab.cs.uiowa.edu/cgi-bin/HPD/cg.cgi). The following
parameters were used: minimum CpG island length 200 bp, minimum
CpG content 0.5, and observed/expected CpG ratio 0.6. The genes
from the MAGEX array were divided into three groups: genes
containing (1) a CpG-rich region within first 100 bp of cDNA
sequence; (2) CpG-rich region(s) outside the first 100 bp of cDNA
sequence; and (3) no CpG-rich regions.
Results
xKaiso is a methyl-CpG dependent transcription
repressor
We identified a Xenopus EST with homology to mammalian
kaiso and subsequent sequencing showed it to be full length
(AY044336). Comparison of the evolutionary conserved
mammalian and xKaiso sequences reveals a domain-specific
divergence in the amino acid sequence of the third zinc finger,
which has only 61% similarity to human kaiso, compared with
90% for the other zinc fingers (Fig. 1A). Because this could
possibly affect the sequence recognition of the ZF domain, we
performed electrophoretic mobility shift assays (EMSA) with
recombinant GST proteins containing the ZF domain. We
found that xKaiso ZFs preferentially bind the methylated Sm
(Me-Sm) DNA sequence, which contains three methylated
CpG pairs (Prokhortchouk et al., 2001). No band shift was
observed with the non-methylated Sm (Non-Sm) oligo (Fig.
1B). Despite the amino acid divergence in the third zinc finger,
the DNA-binding affinity of the xKaiso ZFs for eight other
methyl-CpG containing sequences tested previously for the
Fig. 1. xKaiso is a methyl-CpG dependent transcriptional repressor.
(A) Schematic of xKaiso illustrating the BTB-POZ and zinc-finger
domains and identity and similarity (in %) with human and zebrafish
protein sequences. The blue box indicates a region of high homology
of unknown function. The bar indicates the region used in EMSA
assays. (B) EMSA experiment using recombinant ZF domain of
xKaiso (KaisoZFs) (1, 2, 4, 10, 20 and 40 ng of protein) with Sm
(methylated and non-methylated) or human matrilysin (Hmat)
probes. Arrow indicates the xKaiso ZF specific band shift in the
reaction with methylated Sm, but not with non-methylated Sm or
Hmat probe. (C) EMSA experiment with xKaiso ZF, methylated
(Sm) probe and non-labelled competitors: either methylated or non-
methylated Sm, or Hmat, at 5, 10,100, 1000 molar excess.
No competitor is added to the reaction in the first lane. xKaiso ZF
specific band (arrow) completely disappears at 1000 molar excess
of methylated Sm. Non-methylated Sm oligo shows virtually no
competition with the methylated Sm probe. The xKaiso ZF band in
the presence of 1000 molar excess of Hmat competitor is stronger
than in the presence of 100 molar excess of methylated non-
labelled Sm oligo. (D) Methyl-CpG-dependent repression by xKaiso
in a transient transfection assay. Kaiso expression constructs were
co-transfected with an SV40-luciferase reporter into mouse cells that
are compromised in methyl-CpG-dependent transcriptional
repression (Mbd2–/–). Relative percentage (methylated reporter
expression/nonmethylated reporter expression) is the average of at
least three experiments. Human kaiso (hKaiso) and human MeCP2
(MeCP2) expression constructs were used as positive controls for
methyl-CpG dependent transcriptional repression.
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human homologue (Prokhortchouk et al., 2001) displayed the
same preference for two adjacent methyl-CpGs in the
substrate, as the presence of intervening nucleotides reduced
binding (data not shown). However, the xKaiso ZF domain was
more specific for methylated DNA than its human counterpart:
it did not copy the affinity of human kaiso for the non-
methylated matrilysin (Hmat) sequence in EMSA (Fig. 1B,
Fig. 3I). In a competition experiment, the matrilysin oligo was
at most one-tenth as efficient a competitor compared with Me-
Sm itself (Fig. 1C). Together, these results suggests that the
xKaiso ZF domain has a preference for methylated DNA, but
differs from human kaiso in its ability to bind certain non-
methylated sequences.
xKaiso has transcription repression activity when targeted to
a GAL4-responsive luciferase reporter in Xenopus embryos
(Kim et al., 2002). We verified whether xKaiso, like human
kaiso, can repress transcription in a methyl-CpG dependent
manner, using murine Mbd2–/– cells that are defective in their
ability to repress expression from a methylated reporter gene
(Hendrich et al., 2001; Prokhortchouk et al., 2001). In this cell
line, a normally silent, fully CpG-methylated reporter gene was
de-repressed to ~15% of control non-methylated reporter
transcription activity. Expression of either xKaiso or human
kaiso in this cell line restored repression from the methylated
reporter, but not from the non-methylated control (Fig. 1D, and
data not shown). Thus, xKaiso shows the same ability to
repress transcription from a methylated reporter gene in the
Mbd2–/– cell system as its mammalian homologue
(Prokhortchouk et al., 2001).
xKaiso is essential for Xenopus development
To analyse xKaiso function during development, we injected
Xenopus two-cell stage embryos with a stabilised antisense
xKaiso morpholino oligonucleotide (KMO) corresponding to
the 5′-UTR and first six codons (see Materials and methods).
This efficiently blocks xKaiso protein translation (Fig. 2G).
Injection with 10 ng of a control non-inhibitory morpholino
(CMO) resulted in normal development (see Table S1 in the
supplementary material; Fig. 2A). By contrast, embryos
injected with 0.5-10 ng KMO morpholino failed to develop
and exhibited a variety of dose-dependent phenotypes (see
Table S1 in the supplementary material; Fig. 2B-E). The
characteristic feature of the 5 ng KMO-injected embryos is the
appearance of white apoptopic cells near the edge of the
blastopore in neurulating embryos (Fig. 2B-D; Fig. 4). By
stages 21-22, the KMO embryos are developmentally arrested
and the embryo surface is covered with apoptotic cells that are
associated with cell shedding (Fig. 2C). Injection of a low dose
(0.5 ng) of KMO into two-cell stage embryos led to a less
severe phenotype with a delay in blastopore closure at stage 15
(Fig. 2D); many of these embryos exhibited short axis or
reduced dorsal structures (spina bifida) by tadpole stage (Fig.
2E). Phenotypically, the effect of the KMO injection was
similar to that of xDnmt1 depletion (Fig. 2F) (Stancheva et al.,
2001; Stancheva and Meehan, 2000). This overlap with the
effects of loss of DNA methylation suggests that xKaiso may
be responsible for mediating silencing of methylated genes in
pre-MBT embryos, and is equally essential to their survival.
A functional methyl CpG binding domain is required
to rescue KMO injected embryos
To ascertain the specificity of the KMO injection phenotype,
we tried to rescue them by co-injection with human kaiso
RNA, which will not bind the KMO because of sequence
differences. Embryos injected at the two-cell stage with 750 pg
of wild type human kaiso RNA developed normally (see Table
S1 in the supplementary material, compare Fig. 3A,B). Co-
injection of 5 ng KMO with 750 pg of wild type human kaiso
enabled over half of the embryos (56%) to successfully
complete neurulation compared with none for the KMO alone
(see Table S1 in the supplementary material). By tadpole stage,
26% of KMO/750 pg wild type human kaiso injected embryos
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Fig. 2. The phenotypes of xKaiso-depleted embryos. (A) Embryos
injected at two-cell stage with 10 ng of a control morpholino (CMO)
show normal neurulation (stage 15). (B) Injection of 5 ng of the
xKaiso morpholino (KMO) leads to a failure of blastopore closure
and developmental arrest of neurulation at stage 15. Arrows indicate
the appearance of white apoptotic cells from the borders of the
blastopore. (C) Apoptotic cells (arrowed) cover almost the entire
surface of embryos at stage 21 and cell shedding is present.
(D) Injection of low dose (0.5 ng) of KMO causes defects of
neurulation and delay of blastopore closure. Apoptotic cells are
arrowed. (E) The range of phenotypes produced at low dose (0.5 ng)
of KMO: 44% of embryos look normal by stage 38 (upper embryo),
29% exhibit failure to develop normal dorsal structures (spina bifida,
lower embryo). Other phenotypes are intermediate. (F) Embryos
injected with 10 ng of xDnmt1 morpholino (DMO) show apoptotic
phenotype virtually identical to that of 5 ng KMO. (G) Western blot
using anti-xKaiso antibody and whole embryonic extracts derived
from wild type (WT) and 5 ng KMO-injected embryos (KMO).
Stages of development are indicated above the lanes. The kaiso-
specific band in KMO-injected embryos disappears by stage 10.
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had developed normally, while 15% exhibited axial defects
(see Table S1 in the supplementary material, Fig. 3C). We also
attempted to rescue the KMO-induced phenotype with a
mutant human kaiso RNA carrying a cysteine to arginine
substitution at position 552 (C552R) in the third zinc finger
(Fig. 3F). This disrupts the human kaiso DNA and methyl-
CpG-dependent binding activity but not the ability to bind its
interacting partner, p120ctn (Fig. 3H,I) (Daniel and Reynolds,
1999). Embryos injected with 5 ng of KMO and 750 pg of
C522R RNA showed exactly the same phenotype as those
injected with 5 ng KMO only, without any (even partial) rescue
(see Table S1 in the supplementary material, Fig. 3D,E). These
experiments strongly suggest that the DNA binding function of
human kaiso is required to rescue KMO-injected embryos.
Kaiso-depleted embryos are apoptotic
xDnmt1 depletion in Xenopus embryos results in induction of
apoptosis (Stancheva et al., 2001). We therefore checked
whether KMO-injected embryos were apoptotic, using the
whole-mount TUNEL assay, a highly sensitive indicator of
DNA fragmentation in situ (Hensey and Gautier, 1998;
Stancheva et al., 2001). A small number (1-2%) of non-injected
control embryos have low levels of apoptotic cells that are
restricted mainly to the developing nervous system at later
stages of neurulation (Fig. 4A-C) (Hensey and Gautier, 1998).
By contrast, in 11% of embryos injected at the two-cell stage
with 5 ng of KMO, a small number of TUNEL-positive cells
already appeared at late blastula stage (Fig. 4D). Fifteen
percent of KMO injected embryos showed TUNEL-positive
cells at mid-gastrula stage 11, mainly restricted to the
ectodermal layer (Fig. 4E). By neurulation, a general pattern
Fig. 3. The methyl-CpG binding function of kaiso is required to
rescue the xKaiso knockdown phenotype. The percentages of
presented phenotypes are indicated. (A) Embryos injected with 10 ng
of CMO develop normally by tadpole stage. (B) Over-expression of
750 pg wild-type human kaiso RNA does not affect normal
development of Xenopus embryos. (C) Injection of 750 pg of wild-
type human kaiso RNA together with 5 ng KMO leads to complete
rescue of 26% of the embryos. (D) Apoptotic phenotype produced by
injection of 5 ng KMO. (E) Co-injection of 750 pg of C522R human
kaiso mutant RNA with 5 ng KMO cannot rescue the phenotype of
xKaiso depletion. (F) Location of the kaiso mutant C522R amino
acid substitution (red) in the third zinc finger, leading to loss of the
ability to bind methylated DNA. (G) Protein gel of recombinant
wild-type human kaiso and C522R (C>R) mutant proteins (arrow).
(H) Pull-down experiment showing p120ctn (arrow) binds both wild-
type human kaiso and C522R (C>R) mutant proteins in vitro, but not
human kaiso protein lacking the ZF domain (∆ZF). (I) EMSA
experiment using recombinant C522R (C>R) mutant and wild-type
human kaiso proteins with methylated (lanes 1, 4), non-methylated
Sm oligos (lanes 2, 5) and human matrilysin (Hmat) oligo (lanes 3,
6) as probes. The kaiso-specific band shift is arrowed. The C522R
mutant shows no DNA-binding activity.
Fig. 4. The loss of xKaiso induces an apoptotic response in Xenopus
embryos. Wild-type (A-C) and 5 ng KMO-injected (D-F) Xenopus
embryos were assayed by TUNEL for the appearance of apoptotic
cells. TUNEL-positive cells were not detectable in normal late
blastula (A) and gastrula (B) embryos. Small numbers of apoptotic
cells (arrowhead) appeared in 1-2% of wild-type embryos at late
neurula stage (C). TUNEL-positive cells were detected in 11% and
15% of KMO-injected embryos at late blastula (D) and gastrula
stages (E), respectively. More than 90% of KMO-injected embryos
exhibited a general pattern of apoptosis at a stage corresponding to
late neurula of normally developing embryos (F). Abbreviations: bp,
blastopore; ant, anterior; post, posterior.
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of apoptosis was detected in more than 90% of KMO-injected
embryos (Fig. 4F), consistent with their visible appearance
(Fig. 2C), and development was arrested. Overall, the cellular
apoptotic patterns caused by xKaiso depletion are similar
to those observed for xDnmt1-deficient embryos, further
emphasizing the functional equivalence of loss of this CpG-
dependent repressor, or loss of CpG methylation itself.
Loss of xKaiso activity results in premature
activation of gene expression in blastula stage
embryos
Reduction in genomic levels of 5mC in Xenopus embryos
results in transcription activation approximately two cycles
earlier than normal (Stancheva et al., 2002; Stancheva and
Meehan, 2000). We tested for premature activation of zygotic
transcription in xKaiso-depleted embryos by measuring the
incorporation of α-35S labelled UTP in KMO-injected and
control embryos at blastula and gastrula stages (Newport and
Kirschner, 1982a; Newport and Kirschner, 1982b; Stancheva
and Meehan, 2000). As expected, control embryos begin to
incorporate label above background after MBT. By contrast,
35S-UTP incorporation in xKaiso-depleted embryos was
detected two cell cycles earlier (Fig. 5A), as had been
previously described for xDnmt1-depleted embryos (Stancheva
and Meehan, 2000). In diploid embryos, premature global
activation has only been observed upon xDnmt1 depletion. This
strongly suggests that xDnmt1 and xKaiso may participate in
the same pathway to silence genes in pre-MBT embryos.
In a cDNA screen, we have identified transcripts that are
upregulated in pre-MBT embryos hypomethylated as a result
of xDnmt1 depletion (D.D. and R.M., unpublished). Three
examples (xOct-25, xBef and xDrak) are shown in Fig. 5B;
derepression also occurred in KMO-injected embryos but was
less marked than that observed for xDnmt1 depletion. All
transcripts that were upregulated in KMO-injected blastula
embryos were also upregulated in DMO embryos (D.D. and
R.M., unpublished).
xKaiso is a genome wide repressor of transcription
in the developing embryo
Our results suggest that the methyl-CpG-dependent repression
function of xKaiso is required to maintain transcriptional
silence in pre-MBT Xenopus embryos. To explore the capacity
of xKaiso as a general transcription repressor, we screened a
Xenopus cDNA mini-array with cDNA probes synthesized
from pre-MBT stage 8 wild-type embryos (WT8), and
xKaiso morpholino-injected (KMO8) and xKaiso morpholino/
human kaiso mRNA co-injected (KMO8rescue) embryos.
The fold expression changes between KMO8:WT8 and
KMO8rescue:WT8 were computed using ScanAlyze and
compared using a threshold of 1.5-fold expression change (Fig.
6A; Table S2 in the supplementary material). Fifty-seven genes
(13%) were misregulated in the KMO:WT8 experiments, of
which 55 (96%) were upregulated 1.5-fold or more in KMO8
embryos, and two genes [Mad2 and p33 ringo (ls26)] exhibited
a decrease in expression relative to WT8 embryos (Fig. 6A).
Many (25/55) of the genes upregulated in KMO8 were in the
range of a 5- to 10-fold increase. We observed a similar change
in expression pattern for this gene set in xDnmt1-deficient
embryos (D.D. and R.M., unpublished). By sharp contrast, the
overexpression of the 55 genes analysed in the KMO8:WT8
comparison was largely neutralised in KMO8rescue embryos.
Only 18 (31%) of the genes were greater than 1.5 upregulated
(e.g. GemH1, xMEK2, CycA1 and CycB2 in Fig. 6A,B). Six
genes (11%) were essentially expressed at similar levels, while
expression of the remainder (58%) was reduced in KMO8rescue
embryos. This suggests that the rescued embryos have reduced
levels of ectopic gene activation compared with xKaiso-
depleted embryos.
The 55 genes that were up-regulated in the KMO:WT
experiments did not represent 13% of genes across the board.
Some functional categories, such as ‘cell growth control’ (27%
of genes affected, P<0.0003) and ‘chromatin/DNA structure’
(15%, P<0.02), were enriched over twofold relative to the input
array, whereas others, in particular ‘transcription’ (6%,
P<0.0003), were significantly underrepresented (Fig. 7A,B).
This is in marked contrast to the genes showing increased
levels of expression at normal MBT (Altmann et al., 2001),
where approximately half of the genes are involved in
transcription (24%), regulatory functions (17%) and signal
transduction (10%). After MBT, a greater number of the
downregulated genes were involved with energy metabolism
(16%) and significantly fewer genes serve regulatory functions
(2%) (Altmann et al., 2001), whereas downregulated genes
were an exception in the KMO:WT set (Fig. 7B).
In previous work we demonstrated that genes that are
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Fig. 5. xKaiso depletion leads to premature activation of transcription
of a subset of genes regulated by xDnmt1. (A) [α-35S]UTP
incorporation detecting the activation of gene expression in wild-type
(WT) and 0.5 ng KMO-injected embryos. WT and KMO-injected
two-cell embryos were treated with 50 nCi [α-35S]UTP, cultured in
parallel and collected at the same developmental stage. (B) RNA
derived from wild type, 5 ng KMO and 5 ng DMO (xDnmt1
morpholino) injected embryos at stage 8 were assayed by RT-PCR
for the presence of transcripts of genes (xOct-25, xBef, xDrak1)
regulated by xKaiso and xDnmt1, respectively, with xODC as a
loading control.
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regulated by DNA methylation at MBT contain
clusters of CpGs at their promoters, so called ‘CpG
islands’, which are methylated in pre-MBT embryos
(Stancheva et al., 2002). At present, the Xenopus
laevis genome has not been sequenced. However, it
is possible to identify potential CpG island regions
in the 5′ region of the MAGEX cDNAs based on the
assumption that the initial 5′sequence (first exon)
overlaps with the promoter region (Bird, 1986;
Tykocinski and Max, 1984). On this basis, 30% of
the genes on the MAGEX array contain potential
CpG islands and 38% percent do not (Fig. 7C). The
remaining 32% contains CpG rich sequences outside
the 5′ region. In the KMO:WT set of cDNAs, the
proportion of potential CpG island containing genes
is enriched (52% compared with 30%, P<0.00004;
Fig. 7D). If these regions are methylated in pre-MBT
embryos, then they may represent direct targets
for xKaiso-dependent silencing during early
development.
Discussion
In the developing embryo, the midblastula transition
(MBT) marks the time point when dependence on
maternal transcripts gives way to the start of zygotic
transcription (maternal-zygotic transcription, MZT).
This key event in the development of all metazoans
takes place early after the first few cell divisions in
mammalian embryos, but occurs at later stages in
embryo species sustained on large supplies of
maternal RNA. In amphibians, where the MBT was
first noted (Newport and Kirschner, 1982a; Newport
and Kirschner, 1982b), the transition is preceded by
a period of transcriptional silence lasting 12 cell
divisions. DNA methylation has a clearly identified
role in the regulation of developmental gene
activation at the MBT (Stancheva et al., 2001;
Stancheva et al., 2002; Stancheva and Meehan,
2000). Loss of methylation at individual Xenopus
gene promoters coincides with their zygotic
activation at MBT. No changes in methylation
patterns are observed for repeated sequences, genes
that are inactive at MBT, or in coding regions
(Stancheva et al., 2002). Experimentally induced
depletion of DNA methylation in the developing
embryo causes premature activation of zygotic gene
transcription at least two cell cycles earlier than
normal. This incorrect timing of the MBT leads to
developmental arrest and cell death (Stancheva et al.,
2001). Loss of DNA methylation is also deleterious
to mammalian development (Jackson-Grusby et al., 2001; Lei
et al., 1996).
The mechanism by which transcriptional silencing is
maintained in early development is not clear. CpG methylation
can directly inhibit transcription factor binding or affect
nucleosome positioning (Davey et al., 2004; Meehan, 2003),
but it is also a target for methyl-CpG binding domain (MBD)-
containing proteins such as MeCP2, MBD1 and MBD2.
However, the absence of these proteins in MeCP2-, MBD1-
and MBD2-null mice does not have the same deleterious
consequences as Dnmt1 depletion (Chen et al., 2001; Guy et
al., 2001; Hendrich et al., 2001; Li et al., 1992; Tudor et al.,
2002; Zhao et al., 2003). This could be due to functional
redundancy between MBD proteins. However, this does not
seem to be the case for MBD2 and MeCP2 (Guy et al., 2001).
Possibly, the exceptionally early MZT before the first cell
division in mice is functionally different from the period of
transcriptional quiescence typical for other organisms
(Beaujean et al., 2004a; Beaujean et al., 2004b). A further
difference exists in the DNA binding ability of MBD3:
Fig. 6. Depletion of xKaiso relieves transcriptional silence but can be rescued
by overexpression of human kaiso mRNA. (A) Two array experiment
comparisons were performed: WT8 versus KMO8 and WT8 versus
KMO8rescue. The x-axis shows 57 genes that were differentially expressed over
a minimum 1.5-fold threshold, and the y-axis shows the fold expression
changes. Genes that are elevated in KMO8 or KMO8rescue relative to wild-type
expression are shown in blue, and downregulated genes in red. (B) A
representative array region showing the expression changes of five genes
[Histone H1 (H1), Geminin H (GemH), cyclin A1 (CycA1), cyclin B2
(CycB2) and MEK1 (MEK1)], which are also indicated on the graph of genes
shown in A. H1 expression was not rescued in KMO8rescue embryos, whereas
CycB2 is, and GemH, MEK1 and CycA1 have reduced expression levels.
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Xenopus contains an MBD3 isoform that, unlike its
mammalian counterpart, binds to methylated DNA (Wade
et al., 1999). This is due to a tyrosine to phenylalanine
substitution at position 29 of the MBD that is crucial for
contacts with the phosphate backbone (Saito and Ishikawa,
2002). Alternatively, additional methyl-CpG activities could
exist that mediate global silencing of methylated genes in
animals.
In this work, we identify xKaiso as the likely candidate for
mediating CpG methylation-dependent gene repression in the
developing embryo. Kaiso is a transcription repressor with a
distinct methyl-CpG binding ability contained in its zinc-finger
domain. We demonstrate that despite considerable amino acid
divergence in the third zinc-finger motif, xKaiso binds
methylated DNA in vitro with a similar binding specificity to
its mammalian counterpart, but with less non-methylated DNA
sequence specificity than observed for mouse kaiso (Daniel et
al., 2002). In addition, we show that ectopic expression of
xKaiso in MBD2–/– deficient fibroblasts restores repression of
a methylated reporter construct, establishing its credentials as
a CpG methylation-dependent repressor, rather than a general
transcription repressor (Kim et al., 2002). In stark contrast with
the minor consequences of depletion/knockouts of MBD
proteins in mouse, xKaiso is essential for normal Xenopus
development. An xKaiso knockdown mimics xDnmt1
depletion in every aspect studied: embryos show precocious
activation of gene expression, apoptosis and developmental
arrest. The specificity of the depletion phenotype and
functional conservation was demonstrated by expressing
human kaiso in Xenopus KMO embryos. This rescued a high
proportion of these embryos, while enabling a majority to
complete neurulation. Importantly, a mutation in the third zinc
finger that abolished the ability of kaiso to bind methylated
DNA could not rescue the KMO phenotype. Our results
strongly suggest that the main developmental changes
observed after loss of CpG methylation are normally under
control of the xKaiso transcriptional repressor and dependent
on its methyl CpG binding domain.
Our gene array data reveal that xKaiso may control more
than 10% of genes in early development. This is consistent with
an important role for xKaiso in these processes, its absence
leading to developmental arrest. The reported interaction with
p120ctn is interesting with regard to the possible role of kaiso
in the MBT. Apart from the onset of zygotic transcription, the
MBT is also associated with the slowing of cell division and
the onset of cell migration (Masui and Wang, 1998; Veenstra,
2002). The p120ctn interaction links E-cadherin cell adhesion
with transcription in the nucleus, and loss of this connection
may be responsible for the dose-dependent effects of xKaiso
depletion on gastrulation movements. Loss of cell adhesion is
observed with xDnmt1 as well as kaiso knockdown embryonic
tissues (I.S., A.R. and R.M., unpublished). Over-expression
experiments nevertheless do not support a mutual inhibition
mechanism for p120ctn versus kaiso function in vivo. Milder
phenotypes result from over-expression of murine p120ctn or
reduction of xp120ctn in Xenopus compared with kaiso
depletion (Fang et al., 2004; Geis et al., 1998; Paulson et al.,
1999). Conversely, an excess of kaiso does not appear to
disturb essential developmental processes, as our embryo
controls developed normally when injected with 750 pg of
wild-type human kaiso RNA. The point mutant C552R-kaiso
is able to bind p120ctn, but could not rescue the depletion
phenotype through a p120ctn-mediated pathway.
xKaiso depletion, like xDnmt1, causes the premature
activation of gene transcription at least two cycles prior to MBT.
Our results indicate that it is unlikely that the MBT is simply
brought forward; rather, gene silencing is relieved outside the
normal context of the MBT. This unscheduled entry into
transcription is not accompanied by the increase in transcription-
related gene products normally observed at the MBT (Altmann
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Fig. 7. xKaiso-repressed
genes: functional categories.
(A) The 429 input (Total)
genes and 55 genes
upregulated relative to WT
in Kaiso-depleted embryos
(KMO/WT) were
categorized as described
(http://www.viagenx.ca/)
and their distributions
shown in separate pie
charts. The numbers refer to
the percentages of genes in
each functional category in
the left/right chart
respectively. (B) CpG island
analysis of the input (Total)
and KMO/WT upregulated
genes is shown in separate
pie charts. Colour coding
for the different groupings
and their percentages of the
total in each chart are shown
on the right.
6193DNA methylation and development
et al., 2001). Levels of maternal mRNA and/or cytoplasmic
volume may trigger this production of transcription machinery
independently (Masui and Wang, 1998; Veenstra, 2002). The
premature transcription we observe could therefore be rate
limiting with regards to these components.
However, it is clear that xKaiso normally represses an
abundance of genes involved in cell growth and control. Only a
small set of this class of genes is normally activated at MBT
(Altmann et al., 2001). This specialisation of a methylation-
dependent transcription repressor is perhaps not surprising in
view of the role of DNA methylation in cancer. It is also
consistent with the observation of tumours in xDnmt1-depleted,
apoptosis-inactivated Xenopus embryos (Stancheva et al., 2001).
We demonstrate that apoptosis is triggered by the depletion of
xKaiso, as observed with Dnmt1 depletion. Elevated expression
in both xKaiso- and xDnmt1-deficient pre-MBT embryos
suggest a common pathway of repression of a set of candidate
genes previously implicated in MBT (Stancheva and Meehan,
2000). Their scheduled release from repression implies a
regulatory control over the methylation-dependent repression
pathway subject to developmental checkpoints by apoptosis.
Receptor signalling pathways could be involved based on the
recruitment of N-CoR in association with HDAC3 observed for
human kaiso at the human MTA2 gene, when abnormally
methylated in HeLa cells (Yoon et al., 2003). N-CoR is
expressed at all stages of Xenopus development and may also be
required to mediate transcriptional silencing in pre-MBT
embryos (Koide et al., 2001). In addition, methylation mapping
data suggest that Dnmt1 may contribute specificity by selectively
maintaining CpG methylation at certain loci while total levels
decrease prior to the MBT (Stancheva et al., 2002). It is also
possible that xMBD3, which has been shown to be part of the
NuRD repressor complex has a general role in developmental
gene activation at MBT and preliminary analysis suggests that
it is also essential for Xenopus development (D.D. and R.M.,
unpublished) (Iwano et al., 2004).
The point at which embryonic transcription initiates in
mammals varies between species with MZT occurring at the
end of the one-cell stage in mice, the four- to eight-cell stage
in humans, and at the eight- to 16-cell stage in rabbits, sheep
and cattle (Kanka, 2003). Amphibians, and also zebrafish
(Martin et al., 1999), exemplify the situation where high initial
levels of CpG methylation correlate with transcriptional
quiescence in the presence of large supplies of maternal
transcripts. In species where the MZT occurs after more than
one cleavage, transcriptional silence is likely to be maintained
because of a non-permissive chromatin state that may involve
DNA methylation and methyl-CpG repressor proteins, such as
xKaiso. Our results raise the issue of whether the global role
of xKaiso in CpG-dependent transcriptional silence is specific
to early development. The indications are that MBD1, MBD2
and MeCP2 are not required to regulate MZT; instead they are
used at later stages of development (Jaenisch and Bird, 2003;
Stancheva et al., 2003).
A key point is that CpG methylation in differentiated
somatic cells is implicated in stable gene silencing that may
involve the sequestering of genes in the heterochromatic (late
replicating) compartment of the nucleus. This is associated
with the restriction of developmental potential and
maintenance of differentiation. A very different situation
applies to the pre-MBT embryo, where the genome is quiescent
but in fact poised to start transcription at MZT to provide a
pluripotent cell type. We propose that this poised repression,
which is different from stable silencing, requires xKaiso, a
transcriptional repressor (rather than silencing mediator) with
connections to signalling pathways that permit the scheduled
release from transcriptional quiescence at MZT.
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